A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in french canadians

New England Journal of Medicine

Volumn 324, Issue 25, 1991, Pages 1761-1766

  ma, Yuanhong ^a   Henderson, Howard E ^a   Monsalve, Maria V ^a   Clarke, Lorne A ^a   Hayden, Michael R ^a   Ven Murthy, M R ^b   Normand, Thierry ^b   Julien, Pierre ^c   Gagné, Claude ^c   Lupien, Paul J ^c   Lambert, Marie ^d   Roederer, Ghislaine ^e   Davignon, Jean ^e   Brunzell, John ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Department of Biochemistry ^*  (United States)

^c Lipid Research Centre ^*  (United States)

^d UNIVERSITÉ LAVAL   (Canada)

^e Clinical Research Institute of Montreal ^*  (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; DNA; LIPOPROTEIN LIPASE;

ARTICLE; BLOOD; CANADA; ETHNOLOGY; FRANCE; GENETICS; HUMAN; MOLECULAR GENETICS; MUTAGENESIS; MUTATION; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; NUTRITIONAL DEFICIENCY;

BASE SEQUENCE; CANADA; CHYLOMICRONS; DNA; FRANCE; HUMAN; LIPOPROTEIN LIPASE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; NUCLEIC ACID HYBRIDIZATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026428636     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199106203242502     Document Type: Article

References (31)

1. Nikkilä EA. Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983:622–42.
2. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 1978; 298:1265–73.
3. Brunzell JD, Miller NE, Alaupovic P, et al. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res 1983; 24:12–9.
4. Gagne C, Brun LD, Julien P, Moorjani S, Lupien PJ. Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population. Can Med Assoc J 1989; 140:405–11.
5. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. Vol. 1. New York: McGraw-Hill. 1989:1165–80.
6. Cheng CF, Oosta GM, Bensadoun A, Rosenberg RD. Binding of lipoprotein lipase to endothelial cells in culture. J Biol Chem 1981; 256:12893–8.
7. Cupp M, Bensadoun A, Melford K. Heparin decreases the degradation rate of lipoprotein lipase in adipocytes. J Biol Chem 1987; 262:6383–8.
8. Wion KL, Kirchgessner TG, Lusis AJ, Schotz MC, Lawn RM. Human lipoprotein lipase complementary DNA sequence. Science 1987; 235:1638–41.
9. Sparkes RS, Zollman S, Klisak I, et al. Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1987; 1:138–44.
10. Deeb SS, Peng R. Structure of the human lipoprotein lipase gene. Biochemistry 1989; 28:4131–5.
11. Erratum, Biochemistry 1989; 28: 6786.
12. Devlin RH, Deeb S, Brunzell J, Hayden MR. Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency. Am J Hum Genet 1990; 46:112–9.
13. Langlois S, Deeb S, Brunzell JD, Kastelein JJP, Hayden MR. A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci U S A 1989; 86:948–52.
14. Ameis D, Kobayashi J, Davis RC, et al. Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene. J Clin Invest 1991; 87:1165–70.
15. Beg OU, Meng MS, Skarlatos SI, et al. Lipoprotein lipaseBelhesda: a single amino acid substitution (Ala176→Thr) leads to abnormal heparin binding and loss of enzymic activity. Proc Natl Acad Sci U S A 1990; 87:3474–8.
16. Emi M, Wilson DE, Iverius PH, et al. Missense mutation (Gly→Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem 1990; 265:5910–6.
17. Monsalve MV, Henderson H, Roederer G, et al. A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J Clin Invest 1990; 86:728–34.
18. Emi M, Hata A, Robertson M, Iverius PH, Hegele R, Lalouel JM. Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene. Am J Hum Genet 1990; 47:107–11.
19. Hata A, Emi M, Luc G, et al. Compound heterozygote for lipoprotein lipase deficiency: Ser→Thr244 and transition in 3′ splice site of intron 2 (AG→AA) in the lipoprotein lipase gene. Am J Hum Genet 1990; 47:721–6.
20. Henderson HE, Ma Y, Hassan MF, et al. Amino acid substitution (He→Thr194) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands: support for a multicentric origin. J Clin Invest 1991; 87:2005–11.
21. Henderson HE, Devlin R, Peterson J, Brunzell JD, Hayden MR. Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency. Mol Biol Med 1990; 7:511–7.
22. Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD. The detection and characterization of the heterozygous state for lipoprotein lipase deficiency. Arteriosclerosis 1989; 9:326–34.
23. Mullenbach R. Lagoda PJ, Welter C. An efficient salt-choloroform extraction of DNA from blood and tissues. Trends Genet 1989; 5: 391.
24. Fisher KL, FitzGerald GA, Lawn RM. Two polymorphisms in the human lipoprotein lipase (LPL) gene. Nucleic Acids Res 1987; 15: 7657.
25. Funke H, Klug J, Assmann G. Hind III RFLP in the lipoprotein lipase gene (LPL). Nucleic Acids Res 1987; 15: 9102.
26. Wang X, Milne R, Marcel Y, Rassart E. A vector that expresses secreted proteins on the cell surface. DNA 1989; 8:753–8.
27. Charbonneau H, Robert N. Origines francaises de la population canadienne, 1608–1759. In: L'atlas historique du Canada. Vol. 1. Des origines a 1800. Montreal: Université de Montreal, 1987:118–9.
28. De Braekeleer M, Dionne C, Gagne C, et al. Founder effect in familial hyperchylomicronemia among French Canadians of Quebec. Hum Hered (in press).
29. Gordon T, Castelli WP, Hjortlund MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977; 62:707–14.
30. Patsch JR, Prasad S, Gotto AM Jr, Patsch W. High density lipoprotein2: relationships of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80:341–7.
31. Wilson DE, Emi M, Iverius P-H, et al. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990; 86:735–50.